Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440944 · ClinicalTrials.gov registry record · NA
Superior Venous Access, Midline vs Ultrasound IVs
A NA study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03440944 is a NA study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT03440944, a NA study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Obtaining intravenous access (IVA) is the most common procedure performed in the emergency department (ED). Placement of IVA allows for blood work and delivery of intravenous fluids and medications. The implementation of ultrasound guided peripheral IVs (UGPIV) have allowed for ultrasound to be used to place an IV into patients with difficult vein access (DVA). An alternative device to place is a midline catheter (MC). The use of MCs against UGPIV has not been compared in a randomized study. Aim 1: To determine if UGPIVs have a higher failure rate than midline catheters within 72 hours of placement. Aim 2: To collect information to perform a direct cost analysis of UGPIV against that of the midline catheter. Aim 3: Assess patient satisfaction.
Interventions
- DEVICE Midline Catheter
- DEVICE Ultrasound Guided Peripheral IV Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-04-23 |
| Est. Completion | 2021-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03440944
The ClinicalTrials.gov registry entry for NCT03440944 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midline Catheter is the first listed.
NCT03440944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03440944 about?
NCT03440944 is a clinical study titled "Superior Venous Access, Midline vs Ultrasound IVs". Obtaining intravenous access (IVA) is the most common procedure performed in the emergency department (ED). Placement of IVA allows for blood work and delivery of intravenous fluids and medications. The implementation of ultrasound guided peripheral IVs (UGPIV) have allowed for ultrasound to be used...
What is the current status of trial NCT03440944?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2018-04-23. Estimated completion is 2021-01-25.
What interventions are being tested in trial NCT03440944?
The interventions under investigation include: Midline Catheter (DEVICE), Ultrasound Guided Peripheral IV Catheter (DEVICE).
Who is sponsoring clinical trial NCT03440944?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.